Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
465
-
Total 13F shares, excl. options
-
56,728,151
-
Shares change
-
-13,148
-
Total reported value, excl. options
-
$7,039,068,770
-
Value change
-
-$22,114,573
-
Put/Call ratio
-
140%
-
Number of buys
-
203
-
Number of sells
-
-214
-
Price
-
$123.97
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2023
529 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2023.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 465 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,728,151 shares
.
Largest 10 shareholders include BlackRock Inc. (6,879,285 shares), VANGUARD GROUP INC (6,349,093 shares), STATE STREET CORP (2,372,395 shares), LSV ASSET MANAGEMENT (2,316,547 shares), WELLINGTON MANAGEMENT GROUP LLP (1,867,582 shares), JPMORGAN CHASE & CO (1,697,012 shares), SAMLYN CAPITAL, LLC (1,346,230 shares), Polaris Capital Management, LLC (1,296,660 shares), RENAISSANCE TECHNOLOGIES LLC (1,290,109 shares), and Deep Track Capital, LP (1,250,000 shares).
This table shows the top 465 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.